Target intelligence / Profile preview

LSP1 pseudogene 3 (LSP1P3)

Target
LSP1P3
Molecular classification
Other (Pseudogene)
01

Overview

LSP1 pseudogene 3 (LSP1P3) is a non-protein-coding pseudogene related to the LSP1 gene, cataloged under NCBI Gene ID 729862[1][6]. Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional due to mutations or lack of regulatory elements that prevent them from being transcribed or translated into active protein. Although some pseudogenes can exert regulatory roles at the RNA level—such as acting as competing endogenous RNAs (ceRNAs), microRNA decoys, or sources of long noncoding RNAs—there is, as of now, no evidence that LSP1P3 serves such a function. LSP1P3 is not considered a therapeutic target, as it does not encode a functional protein and lacks known direct involvement in disease or therapeutic mechanisms[1][2][6]. Notes on correctness: - LSP1P3 is not a protein-coding gene and is generally not considered a bona fide molecular target (not a receptor, enzyme, transporter, etc.) in pharmacology or drug development[1][6]. - Its inclusion as a target would be incorrect in the context of receptor or drug target lists. It is more appropriate to refer to the parental gene, LSP1 (Lymphocyte-specific protein 1), for protein function and disease association details[3][5]. Pseudogenes like LSP1P3 may gain relevance if future research discovers a noncoding function relevant to disease or therapy—but no such evidence exists currently[2][6].

Other names
LSP1P3
02

Biological functions

Other (Generally no protein-coding or direct biological function; may have noncoding regulatory roles typical of some pseudogenes)
03

Disease associations

Other (Currently, no disease role established for LSP1P3 specifically; some pseudogenes act as regulators in disease, but this is not demonstrated for LSP1P3[1][6])

Beyond the preview

Go deeper on LSP1 pseudogene 3 (LSP1P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LSP1 pseudogene 3 (LSP1P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call